The class action lawsuit adds legal overhang and potential liability. The core issue is the failed Fabric Genomics acquisition and the magnitude of the guidance cut and impairment. Traders should monitor for any settlement or further negative disclosures from the litigation process, and watch for the lead plaintiff deadline on August 3, 2026.
Price Chart
Executive Summary
Robbins LLP announced a securities class action lawsuit against GeneDx Holdings Corp. (WGS) alleging the company misled investors about the benefits of its Fabric Genomics acquisition. The complaint centers on a May 4, 2026 disclosure where GeneDx missed revenue estimates, slashed full-year 2026 revenue guidance from $540M-$550M to $475M-$490M, and recorded a $31.2M impairment on Fabric Genomics, causing a ~49.2% stock decline.
Key Financial Metrics
Key Facts
- Securities class action filed alleging GeneDx misled investors about Fabric Genomics acquisition benefits.
- GeneDx lowered full-year 2026 revenue guidance from $540M-$550M to $475M-$490M.
- GeneDx disclosed a $31.2M impairment loss attributable to Fabric Genomics.
- Stock declined $33.42 per share (~49.2%) following the May 4, 2026 disclosure.
- Lead plaintiff deadline is August 3, 2026.
- Class period: April 16, 2025 to May 4, 2026.
Financial Impact
Revenue guidance cut by ~$65M at midpoint; $31.2M impairment; ~49.2% stock decline.
Risk Factors
- Potential liability from securities class action.
- Further negative revelations about Fabric Genomics or core business.
- Execution risk on revised guidance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302835684 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | Insider Cluster | $85.27 $101.10 | ▲ +18.57% | ▲ +18.79% | $73.09 (−14.28%) |
Sep 1, 2026 4w ago | 144 | $86.72 $83.96 | ▼ −3.18% | ▼ −2.22% | $73.09 (−15.72%) |
Jul 27, 2026 9w ago | Press Release | $61.88 $67.86 | ▼ −9.66% | ▼ −7.39% | $73.09 (−18.12%) |
Jul 23, 2026 10w ago | Press Release | $63.38 $68.96 | ▼ −8.80% | ▼ −8.33% | $73.09 (−15.32%) |
Jun 16, 2026 15w ago | 8-K | $60.60 $58.08 | ▼ −4.16% | ▼ −1.93% | $73.09 (+20.61%) |
Jun 11, 2026 16w ago | Institutional Cluster | $59.92 $59.01 | ▼ −1.52% | ▼ −2.19% | $73.09 (+21.98%) |
Jun 8, 2026 16w ago | Insider Cluster | $56.33 $61.32 | ▲ +8.86% | ▲ +6.45% | $73.09 (+29.75%) |
May 20, 2026 19w ago | Insider Cluster | $47.33 $50.15 | ▲ +5.96% | ▲ +4.36% | $73.09 (+54.43%) |
Mar 26, 2026 27w ago | Insider Cluster | $61.35 $66.20 | ▼ −7.91% | ▼ −6.27% | $73.09 (−19.14%) |
Mar 4, 2026 30w ago | Insider Cluster | $79.47 $85.10 | ▼ −7.08% | ▼ −8.42% | $73.09 (+8.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access